FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292242007> ?p ?o ?g. }

• W4292242007 abstract "The aim of this study was to investigate the comparative efficacy of neuromodulation technologies for overactive bladder (OAB) syndrome in adults.A computerized search was conducted of Cochrane Library, EMBASE, MEDLINE (via PubMed), Web of Science, CNKI, Wan Fang Data, and ClinicalTrials.gov up to April 21, 2022.The search selected clinical trials with random allocation to percutaneous tibial nerve stimulation (PTNS), transcutaneous tibial nerve stimulation (TTNS), vaginal electrical stimulation (VES), sacral neuromodulation (SNM), parasacral stimulation (PS), pudendal neuromodulation, or placebo.The main outcomes were the voiding diary, OAB-related quality of life, and positive response rate. The Cochrane Risk of Bias tool (RoB 2.0) was used to assess the risk of bias of each included study, and the Grading of Recommendations Assessment, Development, and Evaluation tool was used to evaluate the overall evidence quality of key outcomes.The study included 21 randomized controlled trials involving 1433 participants, and all trials were used for the meta-analysis. In the network meta-analyses, five of six neuromodulation technologies, including PTNS, TTNS, VES, SNM, and PS, were related to higher efficacy than the placebo. Ranking probability showed that SNM was the most efficacious therapy for improving OAB-related quality of life, urinary episodes, and urinary frequency. For urgency incontinence episodes and the number of pads, PTNS and TTNS were the most efficacious modalities, respectively.Neuromodulation technologies, including PTNS, TTNS, VES, SNM, and PS, may be effective and safe solutions for OAB syndrome in adults. Moreover, SNM is the most efficacious regimen for OAB-related quality of life, urinary episodes, and urinary frequency. PTNS and TTNS are the most efficacious modalities for reducing urgency incontinence episodes and the number of pads, respectively. Future studies should pay more attention to the quality of study design and report, patients who may benefit the most from neuromodulation, and the long-term effect, cost-effectiveness, and satisfaction of neuromodulation." @default.
• W4292242007 created "2022-08-19" @default.
• W4292242007 creator A5012922372 @default.
• W4292242007 creator A5023316562 @default.
• W4292242007 creator A5030071991 @default.
• W4292242007 creator A5034388034 @default.
• W4292242007 creator A5036670287 @default.
• W4292242007 creator A5070046055 @default.
• W4292242007 creator A5074524768 @default.
• W4292242007 creator A5080622751 @default.
• W4292242007 creator A5081093007 @default.
• W4292242007 date "2022-08-18" @default.
• W4292242007 modified "2023-10-13" @default.
• W4292242007 title "Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials." @default.
• W4292242007 cites W1967347194 @default.
• W4292242007 cites W1974505497 @default.
• W4292242007 cites W1993062994 @default.
• W4292242007 cites W2005947177 @default.
• W4292242007 cites W2010699829 @default.
• W4292242007 cites W2011364198 @default.
• W4292242007 cites W2030223911 @default.
• W4292242007 cites W2068451975 @default.
• W4292242007 cites W2074147400 @default.
• W4292242007 cites W2086806257 @default.
• W4292242007 cites W2091808438 @default.
• W4292242007 cites W2098718880 @default.
• W4292242007 cites W2104675861 @default.
• W4292242007 cites W2107328434 @default.
• W4292242007 cites W2115531508 @default.
• W4292242007 cites W2118985462 @default.
• W4292242007 cites W2133603145 @default.
• W4292242007 cites W2164468685 @default.
• W4292242007 cites W2174235120 @default.
• W4292242007 cites W2518932875 @default.
• W4292242007 cites W2736558198 @default.
• W4292242007 cites W2762309295 @default.
• W4292242007 cites W2783727680 @default.
• W4292242007 cites W2885093393 @default.
• W4292242007 cites W2896300196 @default.
• W4292242007 cites W2896526042 @default.
• W4292242007 cites W2917774245 @default.
• W4292242007 cites W2923193970 @default.
• W4292242007 cites W2923273639 @default.
• W4292242007 cites W2949822323 @default.
• W4292242007 cites W2970684805 @default.
• W4292242007 cites W2999509698 @default.
• W4292242007 cites W3003650235 @default.
• W4292242007 cites W3005126480 @default.
• W4292242007 cites W3006898898 @default.
• W4292242007 cites W3007666198 @default.
• W4292242007 cites W3021370659 @default.
• W4292242007 cites W3089286741 @default.
• W4292242007 cites W3095264776 @default.
• W4292242007 cites W3115447090 @default.
• W4292242007 cites W3119140011 @default.
• W4292242007 cites W3164514369 @default.
• W4292242007 cites W3190843929 @default.
• W4292242007 cites W3191893060 @default.
• W4292242007 cites W3196331132 @default.
• W4292242007 cites W3202169388 @default.
• W4292242007 cites W3208191625 @default.
• W4292242007 cites W3216938298 @default.
• W4292242007 cites W4229083014 @default.
• W4292242007 cites W4253168713 @default.
• W4292242007 doi "https://doi.org/10.1016/j.neurom.2022.06.004" @default.
• W4292242007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35989159" @default.
• W4292242007 hasPublicationYear "2022" @default.
• W4292242007 type Work @default.
• W4292242007 citedByCount "1" @default.
• W4292242007 countsByYear W42922420072023 @default.
• W4292242007 crossrefType "journal-article" @default.
• W4292242007 hasAuthorship W4292242007A5012922372 @default.
• W4292242007 hasAuthorship W4292242007A5023316562 @default.
• W4292242007 hasAuthorship W4292242007A5030071991 @default.
• W4292242007 hasAuthorship W4292242007A5034388034 @default.
• W4292242007 hasAuthorship W4292242007A5036670287 @default.
• W4292242007 hasAuthorship W4292242007A5070046055 @default.
• W4292242007 hasAuthorship W4292242007A5074524768 @default.
• W4292242007 hasAuthorship W4292242007A5080622751 @default.
• W4292242007 hasAuthorship W4292242007A5081093007 @default.
• W4292242007 hasConcept C126322002 @default.
• W4292242007 hasConcept C142724271 @default.
• W4292242007 hasConcept C168563851 @default.
• W4292242007 hasConcept C1862650 @default.
• W4292242007 hasConcept C204787440 @default.
• W4292242007 hasConcept C27081682 @default.
• W4292242007 hasConcept C2776478404 @default.
• W4292242007 hasConcept C2778941218 @default.
• W4292242007 hasConcept C2780118021 @default.
• W4292242007 hasConcept C71924100 @default.
• W4292242007 hasConcept C95190672 @default.
• W4292242007 hasConceptScore W4292242007C126322002 @default.
• W4292242007 hasConceptScore W4292242007C142724271 @default.
• W4292242007 hasConceptScore W4292242007C168563851 @default.
• W4292242007 hasConceptScore W4292242007C1862650 @default.
• W4292242007 hasConceptScore W4292242007C204787440 @default.
• W4292242007 hasConceptScore W4292242007C27081682 @default.
• W4292242007 hasConceptScore W4292242007C2776478404 @default.
• W4292242007 hasConceptScore W4292242007C2778941218 @default.
• W4292242007 hasConceptScore W4292242007C2780118021 @default.

• next